Product Information
LEVOFLOXACIN 25 MG/ML SOLUTION is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.3160 per ML under NDC 70954085210. Its NADAC has been published 133 times since May 8, 2024.
FDA first approved this application on Jun 20, 2011. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Levofloxacin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/mL
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954085210
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
11/18/2026
Active Ingredients
LEVOFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA091678FDA Approved
6/20/2011
TE Code
AA
On Market Since
3/26/2024
Price Statistics
The NADAC for LEVOFLOXACIN 25 MG/ML SOLUTION has been published 133 times since May 8, 2024, and over the history we have for it it has declined 25.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3160 per ML |
|---|---|
| All-time high | $1.9119 (Jul 15, 2026) |
| All-time low | $1.3160 (Nov 18, 2026) |
| 52-week high | $1.9119 |
| 52-week low | $1.3160 |
| Median price | $1.6347 |
| Average price | $1.6407 |
| Largest weekly change | +13.3% (May 20, 2026) |
| Weeks tracked | 133 |
| Tracking since | May 8, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOFLOXACIN 25 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for LEVOFLOXACIN 25 MG/ML SOLUTION, manufactured by ANI Pharmaceuticals, Inc., is $1.3160 per ML (NDC 70954085210), effective Nov 18, 2026.
How has the price of LEVOFLOXACIN 25 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for LEVOFLOXACIN 25 MG/ML SOLUTION has declined 25.5%. It has been tracked across 133 weekly CMS publications since May 8, 2024.
What are the highest and lowest recorded NADAC prices for LEVOFLOXACIN 25 MG/ML SOLUTION?
Since May 8, 2024, the NADAC for LEVOFLOXACIN 25 MG/ML SOLUTION has ranged from a low of $1.3160 (Nov 18, 2026) to a high of $1.9119 (Jul 15, 2026), with a median of $1.6347 per ML.
Are there cheaper alternatives to LEVOFLOXACIN 25 MG/ML SOLUTION?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVOFLOXACIN 25 MG/ML SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVOFLOXACIN 25 MG/ML SOLUTION?
LEVOFLOXACIN 25 MG/ML SOLUTION (NDC 70954085210) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.